Timely diagnosis and management of T1D can reduce the incidence of diabetic ketoacidosis, improve clinical presentation at the onset of stage 3 disease, shorten hospital stays and help preserve beta cell mass—ultimately decreasing initial insulin requirements and reducing both short‐ and long‐term complications [129, 130]. The gene discussed is INS; the disease is type 1 diabetes mellitus.